-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Tectonic Therapeutic, Lowers Price Target to $60

Benzinga·01/08/2026 17:23:56
Listen to the news
Truist Securities analyst Danielle Brill maintains Tectonic Therapeutic (NASDAQ:TECX) with a Buy and lowers the price target from $64 to $60.